Auris to price its IPO of 6.9 million shares at $10.00 to $12.00

Jefferies, Leerink Partners to be joint bookrunning managers for deal

By Devika Patel

Knoxville, Tenn., July 21 – Auris Medical Holding AG will sell 6.9 million common shares in its initial public offering with a 30-day greenshoe of 1,035,000 additional shares, according to a Form F-1/A filed Monday with the Securities and Exchange Commission. The deal was announced June 30.

The shares will be sold at a price expected to fall between $10.00 and $12.00 per share.

Jefferies and Leerink Partners are the joint bookrunning managers. JMP Securities and Needham & Co. are the co-managers.

Proceeds will be used for research and development, working capital and other financial corporate purposes.

The biopharmaceutical company is based in Zug, Switzerland. The company intends to list its common stock on the Nasdaq under the symbol “EARS.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.